Rapid determination of acyclovir, its main metabolite 9-carboxymethoxymethylguanine, ganciclovir, and penciclovir in human serum using LC-MS/MS
2022 (English)In: Biomedical Chromatography, ISSN 0269-3879, E-ISSN 1099-0801, Vol. 36, no 4, article id e5315Article in journal (Refereed) Published
Abstract [en]
A novel MS-based analytical method for simultaneous analysis of the antiviral drugs acyclovir, its metabolite 9-carboxymethoxymethylguanine, ganciclovir, and penciclovir in human serum is described. These antiviral drugs are active against herpes virus infections. Acyclovir and penciclovir are regarded as safe and effective medicines with mild side effects such as headache and gastrointestinal discomfort, and ganciclovir is regarded as more toxic and is known to cause, for example, bone marrow suppression. Acyclovirs main metabolite 9-carboxymethoxymethylguanine is a presumptive neurotoxin and should be monitored in patients with impaired renal function or in cases with neurotoxic symptoms. A sample was prepared using protein precipitation with 1% formic acid in methanol containing isotopically labeled internal standard. Chromatographic separation on a biphenyl column and mass spectrometric detection were performed in multiple reaction monitoring (MRM) mode on a Xevo TQ-S micro with ESI in positive ion mode, within 3 min. Inter-day assay accuracies for the quality controls varied between 95 and 104% and intra-day assay between 93 and 105%. Inter-day and intra-day assay imprecision for the quality controls ranged between 1.4 and 4.2% and 1.7 and 6.5% respectively. The lower limit of quantification for all four substances was 0.156 mu mol/L. It is an accurate and reproducible method for therapeutic drug monitoring.
Place, publisher, year, edition, pages
Oxford, United Kingdom: John Wiley & Sons, 2022. Vol. 36, no 4, article id e5315
Keywords [en]
antiviral agents, LC-MS; MS, serum analysis, therapeutic drug monitoring, validation
National Category
Analytical Chemistry
Identifiers
URN: urn:nbn:se:liu:diva-182778DOI: 10.1002/bmc.5315ISI: 000748176600001PubMedID: 34981553Scopus ID: 2-s2.0-85123833219OAI: oai:DiVA.org:liu-182778DiVA, id: diva2:1637361
2022-02-142022-02-142025-12-01Bibliographically approved